Ashvattha Therapeutics Appoints Life Healthcare Veteran George Montgomery as Executive Chairman to Lead Corporate Development and Strategic Partnerships

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting and reprogramming activated cells in the retina, today announced the appointment of George Montgomery as Executive Chairman, effective immediately. Mr. Montgomery brings over three decades of experience as an investor (private equity and venture capital), a start-up entr